The top ten companies in the USD 6.9 billion Thai pharma market for 2021 ranked by market share, compiled by Thai banking firm Krungsti. Three of the featured firms – Mega Lifesciences, Better Pharma, and Berlin Pharma – are locals, while multinationals of the likes of AstraZeneca, Pfizer, and Novartis make up the remaining seven.
Made with Visme Infographic Maker
Click here to read more articles and interviews from Thailand, and to download the latest free pharma report on the country.
Click here to read more articles and interviews from Thailand, and to download the latest free pharma report on the country.
Click here to read more articles and interviews from Thailand, and to download the latest free pharma report on the country.
Click here to read more articles and interviews from Thailand, and to download the latest free pharma report on the country.
The Thai pharma market, one of the largest in the ASEAN region, stood at USD 4.6 billion in size in 2016. A recent report from the Dutch Embassy in Thailand…
Thailand’s healthcare expenditure is projected to rise from USD 25.3 billion in 2016 to 47.9 billion by 2026, a ten-year CAGR of 6.6%. Made with Visme Infographic Maker According…
The biggest pharma stories from Southeast Asia, including GSK’s new HPF manufacturing investment, license suspensions for Samco Farma and Ciubros Farma after Indonesia’s acute kidney injury crisis, Kalbe’s Aventis share…
Through compassionate use programs patients suffering from critical, life-threatening conditions can access potential life-saving therapeutic options which have not been formally approved by the responsible health authority in an ethical…
Writing in the September edition of DIA’s Global Forum magazine, Rosilawati Ahmad of Malaysia’s National Pharmaceutical Regulatory Agency; Tharnkamol Chanprapaph of the Thai FDA; and Samvel Azatyan, Valerio Reggi, and…
See our Cookie Privacy Policy Here